Anastasia Georgievskaya is doing important work for the longevity revolution, using AI to develop biomarkers from photos of consumers’ skin. Ironically, consumers seem more interested in offers of enhanced attractiveness than of extended lifespan.

Calum Chace examines how Sergey Young, a longevity leader, is funding research to help humans live longer, healthier, and more productive lives, with artificial intelligence and other new technologies potentially expanding the limits of what is currently possible. Will it soon become possible for humans to halt or even reverse aging, and if so, what would be the ethical ramifications of such an outcome?

In an exclusive interview with The Yuan, Lifespark Chief Executive Officer Joel Theisen spoke with Oladimeji Ewumi, and shared insights on how the company is leveraging artificial intelligence to help aging populations live healthier and longer.

Michael Antonov caught ‘the longevity bug’ after helping to found Oculus Rift, the virtual reality headgear company, and selling it to Facebook for US$2.3 billion. He went back to college and taught himself biochemistry, and now he invests in startups which are developing tools to allow us to understand the fabulously complex mechanics of our bodies.

Nico Gariboldi, Site Lead of the Pfizer Center for Digital Innovation, talks to The Yuan about the activities, partnerships, and central role in implementing Pfizer’s digital strategy.